Enhancement of Adjuvant Functions of Natural ...
Title :
Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy
Author(s) :
Ghinnagow, Reem [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Cruz, Luis Javier [Auteur]
Leiden University Medical Center [LUMC]
Macho-Fernandez, Elodie [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Faveeuw, Christelle [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Trottein, Francois [Auteur correspondant]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Cruz, Luis Javier [Auteur]
Leiden University Medical Center [LUMC]
Macho-Fernandez, Elodie [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Faveeuw, Christelle [Auteur]

Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Trottein, Francois [Auteur correspondant]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Journal title :
Frontiers in immunology
Pages :
879
Publisher :
Frontiers
Publication date :
2017-07-27
ISSN :
1664-3224
English keyword(s) :
CTL response
adjuvant
cancer
dendritic cells
nanovaccines
natural killer T cells
α-galactosylceramide
adjuvant
cancer
dendritic cells
nanovaccines
natural killer T cells
α-galactosylceramide
HAL domain(s) :
Sciences du Vivant [q-bio]/Immunologie/Immunité innée
English abstract : [en]
Type I natural killer T (NKT) cells have gained considerable interest in anticancer immune therapy over the last decade. This "innate-like" T lymphocyte subset has the unique ability to recognize foreign and self-derived ...
Show more >Type I natural killer T (NKT) cells have gained considerable interest in anticancer immune therapy over the last decade. This "innate-like" T lymphocyte subset has the unique ability to recognize foreign and self-derived glycolipid antigens in association with the CD1d molecule expressed by antigen-presenting cells. An important property of these cells is to bridge innate and acquired immune responses. The adjuvant function of NKT cells might be exploited in the clinics. In this review, we discuss the approaches currently being used to target NKT cells for cancer therapy. In particular, we highlight ongoing strategies utilizing NKT cell-based nanovaccines to optimize immune therapy.Show less >
Show more >Type I natural killer T (NKT) cells have gained considerable interest in anticancer immune therapy over the last decade. This "innate-like" T lymphocyte subset has the unique ability to recognize foreign and self-derived glycolipid antigens in association with the CD1d molecule expressed by antigen-presenting cells. An important property of these cells is to bridge innate and acquired immune responses. The adjuvant function of NKT cells might be exploited in the clinics. In this review, we discuss the approaches currently being used to target NKT cells for cancer therapy. In particular, we highlight ongoing strategies utilizing NKT cell-based nanovaccines to optimize immune therapy.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Source :
Files
- https://www.hal.inserm.fr/inserm-02436032/document
- Open access
- Access the document
- https://www.hal.inserm.fr/inserm-02436032/document
- Open access
- Access the document
- https://www.hal.inserm.fr/inserm-02436032/document
- Open access
- Access the document
- document
- Open access
- Access the document
- Enhancement_of_adjuvant_fuunctions_of_natural_killer.pdf
- Open access
- Access the document
- Open access
- Access the document
- document
- Open access
- Access the document
- Enhancement_of_adjuvant_fuunctions_of_natural_killer.pdf
- Open access
- Access the document